Plasma levels of C-reactive protein and serum amyloid A and gastric cancer in a nested case-control study: Japan Public Health Center-based prospective study
Authors:
- Shizuka SasazukiSSShizuka Sasazuki
- Manami InoueMIManami Inoue
- Norie SawadaNSNorie Sawada
- Motoki IwasakiMIMotoki Iwasaki
- Taichi ShimazuTSTaichi Shimazu
- Taiki YamajiTYTaiki Yamaji
- Shoichiro TsuganeSTShoichiro Tsugane
- for the Japan Public Health Center-Based Prospective Study GroupFGfor the Japan Public Health Center-Based Prospective Study Group
- 18 January 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 31 (4) , 712-718
Abstract
Gastric carcinogenesis may be under the combined influence of factors related to the host, Helicobacter pylori bacterial virulence and the environment. One possible host-related factor is the inflammatory or immune response. To clarify this point, we investigated the association between plasma levels of C-reactive protein (CRP) and serum amyloid A (SAA) and the subsequent risk of gastric cancer in a population-based nested case–control study. Subjects were observed from 1990 to 2004. Among 36 745 subjects who answered the baseline questionnaire and provided blood samples, 494 gastric cancer cases were identified and matched to 494 controls for our analysis. The overall distribution of CRP and SAA was not apparently associated with the development of gastric cancer. However, a statistically significant increased risk was observed when subjects were categorized dichotomously. The adjusted odds ratio (OR) for the development of gastric cancer for the CRP-positive group (CRP > 0.18 mg/dl) compared with the CRP-negative group was 1.90 [95% confidence interval (CI): 1.19–3.02, P = 0.007]. The OR for the SAA-positive group (SAA > 8 μg/ml) compared with the SAA-negative group was 1.93 (95% CI: 1.22–3.07, P = 0.005). In conclusion, our results suggest that those who react strongly to inflammation or who have a high host immune response, as reflected by extremely elevated plasma levels of CRP and SAA, are at a high risk to develop gastric cancer.Keywords
This publication has 26 references indexed in Scilit:
- Overweight, obesity and gastric cancer risk: Results from a meta-analysis of cohort studiesEuropean Journal of Cancer, 2009
- Evaluation of Serum Amyloid A as a Biomarker for Gastric CancerAnnals of Surgical Oncology, 2006
- Interleukin-8Promoter Polymorphism Increases the Risk of Atrophic Gastritis and Gastric Cancer in JapanCancer Epidemiology, Biomarkers & Prevention, 2005
- Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infectionGut, 2004
- Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancyAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker to Monitor Relapse of Nasopharyngeal Cancer by Serum Proteomic ProfilingClinical Cancer Research, 2004
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinomaCancer Letters, 1995
- Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis.Journal of Clinical Pathology, 1986